论文部分内容阅读
经历1个世纪的探索,人们已充分认识到血脂异常,尤其是低密度脂蛋白胆固醇水平升高与动脉粥样硬化发生发展的密切关系。自上世纪80年代和90年代以来的几项全国性和地区性的流行病学调查显示,随着生活水平的改善,我国人群血脂水平不断升高,冠心病发病率迅速增加,并有向年轻化发展的趋势。血脂异常的防治已成为冠心病一级预防和二级预防的主要策略。然而在我国,血脂异常的低知晓率、低服药率和低达标率与日益增加的血脂异常的发病率之间形成鲜明对比。这种情况是多方面因素造成的,其中广大医生(尤其是基层医生)、患者和公众对血脂异常的危害认识不足是主要原因,这种局面亟待扭转。本刊根据中国胆固醇教育(CCEP)的内容,从本期开始开办“中国胆固醇教育(CCEP)系列讲座”专栏,由本刊常务副总编辑胡大一教授主持,并特别邀请国内有关方面的专家,依据CCEP的要求撰写文章,旨在向广大医生推广规范化的血脂干预方法,缩小临床指南与临床实践之间的差距,提高广大医师和人民群众对血脂异常的认识,搞好冠心病的防治。
After a century of exploration, people have fully recognized the dyslipidemia, especially the high level of low density lipoprotein cholesterol and the development of atherosclerosis is closely related. Since the 1980s and 1990s, several national and regional epidemiological surveys have shown that with the improvement of living standards, the blood lipids in our population have been rising, the incidence of coronary heart disease has been rapidly increasing, The trend of development. Prevention and treatment of dyslipidemia has become the primary prevention of primary coronary heart disease and secondary prevention. However, in our country, there is a sharp contrast between the low awareness of dyslipidemia, the low medication rate and the low compliance rate and the increasing incidence of dyslipidemia. This situation is caused by many factors. Among them, the majority of doctors (especially grassroots doctors), patients and the general public are the main reason for the lack of understanding of the dangers of dyslipidemia. This situation needs to be reversed urgently. According to the contents of China’s Cholesterol Education (CCEP), this edition starts with the column of “China Cholesterol Education (CCEP) Seminar Series” and is presided over by Professor Hu Dayi, Executive Vice Editor-in-Chief of the Journal. In addition, we invite experts from China on the basis of CCEP requirements writing articles designed to promote the standardization of lipid-lowering intervention methods to the majority of doctors, narrowing the gap between clinical guidelines and clinical practice, improve the understanding of the majority of physicians and the people of dyslipidemia, improve the prevention and treatment of coronary heart disease.